• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Pill in the morning prevented type 2

I was intrigued when I saw this as I had read about it a while ago elsewhere, the ACT Now study utilising Pioglitazone. It was started some time in 2004 and the length of time people were trialled on it was at it's longest 4 yrs.

My thought is why has it appeared now as if it is something new.........could it be the Drug Company Takeda Pharmaceutical Co. Ltd makers of Actos (Pioglitazone) who actually sponsored the study wanted to promote their drug by releasing this article to get more interest ? Am I a cynic or what........ :wink:

Not much digging led to this dated June 12 2008. Reported at an ADA Scientific Session in San Francisco on June 9th of that year.........


http://www.uthscsa.edu/hscnews/singlefo ... newID=2773

This 'NEW' article appears to be much the same.....a re-hash of old news...... :wink:
 
Cookies are required to use this site. You must accept them to continue using the site. Learn More.…